CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 92 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | BRAENDER LORI J Corporate Secretary | Shares withheld for taxes | −76,147 | $4.18 | $318K | 366,732 |
| 2026-03-10 | Boyd Peter E. Chief People Officer | Sale | −29,814 | $4.17 | $124K | 338,509 |
| 2026-03-10 | Barber Daniel President and CEO | Sale | −180,677 | $4.17 | $754K | 1,004,753 |
| 2026-03-10 | BRAENDER LORI J Chief Legal Officer | Sale | −40,102 | $4.17 | $167K | 442,879 |
| 2026-03-10 | Cioffi Melina SVP, Regulatory Affairs | Sale | −25,311 | $4.17 | $106K | 274,867 |
| 2026-03-10 | TOTH A ERNEST JR Chief Financial Officer | Sale | −58,254 | $4.17 | $243K | 376,112 |
| 2026-03-10 | Korczynski Sherry Chief Commercial Officer | Sale | −15,741 | $4.17 | $66K | 241,117 |
| 2026-03-10 | Jung Cassie Chief Operating Officer | Sale | −45,791 | $4.17 | $191K | 274,980 |
| 2026-03-09 | Boyd Peter E. Chief People Officer | Grant or award | +80,000 | 368,323 | ||
| 2026-03-09 | Boyd Peter E. Chief People Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +42,500 | $4.29 | $182K | 42,500 |
| 2026-03-09 | Barber Daniel President and CEO | Grant or award | +262,000 | 1,185,430 | ||
| 2026-03-09 | Barber Daniel President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +523,000 | $4.29 | $2.2M | 523,000 |
| 2026-03-09 | BRAENDER LORI J Chief Legal Officer | Grant or award | +80,000 | 482,981 | ||
| 2026-03-09 | BRAENDER LORI J Chief Legal Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +50,000 | $4.29 | $215K | 50,000 |
| 2026-03-09 | Cioffi Melina SVP, Regulatory Affairs | Grant or award | +100,000 | 300,178 | ||
| 2026-03-09 | Cioffi Melina SVP, Regulatory Affairs | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | $4.29 | $322K | 75,000 |
| 2026-03-09 | TOTH A ERNEST JR Chief Financial Officer | Grant or award | +95,000 | 434,366 | ||
| 2026-03-09 | TOTH A ERNEST JR Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2026-03-09 | Korczynski Sherry Chief Commercial Officer | Grant or award | +75,000 | 256,858 | ||
| 2026-03-09 | Korczynski Sherry Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +42,500 | $4.29 | $182K | 42,500 |
Page 3 of 15 · 300 trades